Patent 11859244 was granted and assigned to Singular genomics Systems, Inc. on January, 2024 by the United States Patent and Trademark Office.
Disclosed herein, inter alia, are polynucleotides, supports, kits, and methods of use thereof for amplifying, immobilizing, and sequencing polynucleotides.